Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,850.00
Bid: 11,700.00
Ask: 12,000.00
Change: 200.00 (1.72%)
Spread: 300.00 (2.564%)
Open: 11,900.00
High: 12,000.00
Low: 11,800.00
Prev. Close: 11,650.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update and Notice of Results

25 Jul 2022 07:00

RNS Number : 5214T
Judges Scientific PLC
25 July 2022
 

Judges Scientific Plc

("Judges Scientific", "the Company" or "the Group")

Half Year Trading Update and Notice of Interim Results

Judges Scientific (AIM: JDG), the group focused on acquiring and developing companies in the scientific instrument sector, provides the following update regarding the Group's trading performance for the six-month period ended 30 June 2022.

The period has been one of continued resilience and progress as our Group recovers from the challenges of the pandemic, with much improved travel across most of the Group's markets, whilst still having to navigate worsening supply chain disruptions.

On 23 May 2022, the Group acquired Geotek Holding Limited and Geotek Coring Limited ('Geotek') for a consideration of up to £80m, funded by a new £100m multi-bank facility, which provides the Group with additional capacity to support the Group's buy and build strategy.

References to "Organic" information in this update exclude any contribution from Geotek.

Order intake 

Across the Group, Organic order intake was up 4.2% after a 25.1% gain in H1 2021; this shows 7.8% progress compared to H1 2019 although cannot be considered a full recovery to the pre-Covid growth trajectory. The Group saw growth in North America, up 15.4% (after 41% growth in H1 2021) and the Rest of the World, up 13.1% (after 8% improvement in H1 2021). The Rest of Europe was flat (after 34% growth in H1 last year) reflecting varied performances across the region. China/Hong Kong, which continued to be affected by strict lockdowns over the period, receded 5.1% (after 2% growth in H1 2021). The UK, which had progressed 26% in H1 2021, was down 9.4%. Order intake still varied considerably from business to business, although less so than in H1 2021.

Order book

The Organic order book reached a mid-year record of 21.3 weeks (17.6 weeks at 30 June 2021 and 23 weeks at 1 January 2022), aided by the modest increase in order intake and by the ongoing supply chain difficulties.

Revenue

Organic sales in the first half were up 7% compared with H1 2021. Further progress was hindered by supply chain issues, by staff shortages caused both by recruitment difficulties and by numerous colleagues having to isolate.

First Half Performance and Outlook

The board expects the growth in Organic revenues to have driven improved profitability in H1. Whilst general market conditions remain challenging, our resilient business model, backed up by a strong order book, gives the board confidence that the current market expectations for the full year (revised to include Geotek) will be met. 

 

Notice of Results

The Company intends to announce its interim results for the six months to 30 June 2022 on Thursday 22 September 2022.

 

For further information please contact:

Judges Scientific

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

William Hall

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel: +44 (0) 20 3100 2222

 

Sam Modlin

Justine James

Joe Pederzolli

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 20 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export. 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGZNZZFGZZZ
Date   Source Headline
24th Sep 20147:00 amRNSHalf Yearly Report
16th Sep 20147:00 amRNSNotice of Results
10th Sep 20147:00 amRNSDirector/PDMR Shareholding
8th Aug 20142:29 pmRNSDirector/PDMR Shareholding
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
18th Jul 20143:14 pmRNSHolding(s) in Company
17th Jul 20147:00 amRNSTrading Statement
9th Jul 20145:24 pmRNSDirector/PDMR Shareholding
6th Jun 20143:52 pmRNSDirector/PDMR Shareholding
5th Jun 201412:03 pmRNSIssue of Equity
3rd Jun 20144:15 pmRNSDirector/PDMR Shareholding
23rd May 20143:20 pmRNSExercise of options
22nd May 20147:00 amRNSPayment of deferred consideration for Scientifica
19th May 20143:08 pmRNSExercise of options
12th May 20141:54 pmRNSDirector/PDMR Shareholding
24th Apr 20145:30 pmRNSExercise of Options
10th Apr 201412:01 pmRNSExercise of options
8th Apr 20146:15 pmRNSDirector/PDMR Shareholding
4th Apr 20142:28 pmRNSExercise of Options
28th Mar 20147:00 amRNSFinal Results
10th Mar 201410:00 amRNSNotice of Results
10th Mar 20148:51 amRNSDirector/PDMR Shareholding
7th Feb 20142:53 pmRNSDirector/PDMR Shareholding
24th Jan 20147:00 amRNSTrading Statement
22nd Jan 20142:01 pmRNSExercise of Options
13th Jan 20141:40 pmRNSHolding(s) in Company
10th Jan 20146:00 pmRNSHolding(s) in Company
9th Jan 20144:34 pmRNSDirector/PDMR Shareholding
13th Dec 201310:31 amRNSIssue of Equity
10th Dec 20138:39 amRNSDirector/PDMR Shareholding
4th Dec 20134:06 pmRNSIssue of Equity
26th Nov 20133:31 pmRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSTrading Statement
7th Nov 20132:04 pmRNSDirector/PDMR Shareholding
25th Oct 20135:24 pmRNSHolding(s) in Company
25th Oct 20134:19 pmRNSDirector/PDMR Shareholding
21st Oct 20137:00 amRNSPlacing to raise GBP8.125 million
9th Oct 20131:25 pmRNSDirector/PDMR Shareholding
2nd Oct 20135:47 pmRNSHolding(s) in Company
26th Sep 20137:00 amRNSHalf Yearly Report
17th Sep 20134:17 pmRNSNotice of Results
9th Sep 20134:15 pmRNSDirector/PDMR Shareholding
13th Aug 201312:48 pmRNSHolding(s) in Company
6th Aug 20134:33 pmRNSDirector/PDMR Shareholding
18th Jul 20132:04 pmRNSDirector/PDMR Shareholding
18th Jul 20137:00 amRNSTrading Statement
15th Jul 20134:59 pmRNSExercise of Options
10th Jul 20131:27 pmRNSExercise of options
9th Jul 20137:00 amRNSDirector/PDMR Shareholding and Issue of Equity
27th Jun 20134:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.